Evidence map›Paper›PMID 39200012›Full record

ArticleAntibiotics (Basel, Switzerland)2024

On-Site Inactivation for Disinfection of Antibiotic-Resistant Bacteria in Hospital Effluent by UV and UV-LED.

Takashi Azuma, Masaru Usui, Tomohiro Hasei, Tetsuya Hayashi

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Takashi AzumaDepartment of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki 569-1094, Japan.ORCID 0000-0002-9625-0631
Masaru UsuiFood Microbiology and Food Safety, Department of Health and Environmental Sciences, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu 069-8501, Japan.ORCID 0000-0003-1624-1469
Tomohiro HaseiDepartment of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki 569-1094, Japan.
Tetsuya HayashiDepartment of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki 569-1094, Japan.

Funding

Japan Agency for Medical Research and Development (AMED) JP22fk0108131 and JP23fk0108666Ministry of Education, Culture, Sports, Science, and Technology of Japan 20H02289, 23H03553, and 24K15322Ministry of Health, Labour and Welfare of Japan 21HA1002 and 24HA1003
6 · The paper itself

Abstract

The problem of antimicrobial resistance (AMR) is not limited to the medical field but is also becoming prevalent on a global scale in the environmental field. Environmental water pollution caused by the discharge of wastewater into aquatic environments has caused concern in the context of the sustainable development of modern society. However, there have been few studies focused on the treatment of hospital wastewater, and the potential consequences of this remain unknown. This study evaluated the efficacy of the inactivation of antimicrobial-resistant bacteria (AMRB) and antimicrobial resistance genes (AMRGs) in model wastewater treatment plant (WWTP) wastewater and hospital effluent based on direct ultraviolet (UV) light irradiation provided by a conventional mercury lamp with a peak wavelength of 254 nm and an ultraviolet light-emitting diode (UV-LED) with a peak emission of 280 nm under test conditions in which the irradiance of both was adjusted to the same intensity. The overall results indicated that both UV- and UV-LED-mediated disinfection effectively inactivated the AMRB in both wastewater types (>99.9% after 1-3 min of UV and 3 min of UV-LED treatment). Additionally, AMRGs were also removed (0.2-1.4 log

Indexed as

antimicrobial resistance genes (AMRGs)antimicrobial-resistant bacteria (AMRB)disinfectionhospital wastewaterriver environmentultraviolet-light emitting diode (UV-LED)UV lampwastewater treatment plant (WWTP)

Identifiers

PMID39200012
PMCPMC11350808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.